Interestingly, NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone [14] and FK866 led to either tumor regression or stabilization in a preclinical trial [11]. The gene discussed is NAMPT; the disease is neoplasm.